FARMINGDALE, N.Y., July 10, 2020 (GLOBE NEWSWIRE) — Misonix, Inc. (Nasdaq: MSON) (“Misonix,” the “Company,” “we,” “us” or “our”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced preliminary unaudited fiscal 2020 fourth quarter revenue for the three months ended June 30, 2020. Fiscal Fourth Quarter RevenueMisonix’s revenue …